1. Home
  2. SANA

as of 12-19-2025 3:40pm EST

$4.50
$0.00
-0.11%
Stocks Health Care Medicinal Chemicals and Botanical Products Nasdaq

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Chart Type:
Time Range:
Founded: 2018 Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 1.4B IPO Year: 2021
Target Price: $7.83 AVG Volume (30 days): 5.9M
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.96 EPS Growth: N/A
52 Week Low/High: $1.26 - $7.30 Next Earning Date: 11-06-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered SANA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 65.33%
65.33%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: